Stockreport

Navidea prevails in litigation with lender; shares ahead 10% [Seeking Alpha]

Navidea Biopharmaceuticals, Inc.  (NAVB) 
NASDAQ:AMEX Investor Relations: ir.navidea.com
PDF Navidea prevails in litigation with lender; shares ahead 10% Navidea Biopharmaceuticals ( NAVB +9.5% announcement The court ruled that CRG collected excess remedies over [Read more]